Related Experiment Video
Updated: Jul 15, 2025

Author Spotlight: Advancing Rapid Detection of Respiratory Pathogens Using Microfluidic Chip
Published on: March 29, 2024
Case Report: Metagenomic next-generation sequencing assists in dynamic pathogen monitoring: powerful tool for
Yaoguang Li1,2, Jun Lei1,2, Zhigang Ren2
1Gene Hospital of Henan Province, Precision Medicine Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Background:
Severe community-acquired pneumonia (sCAP) is life-threatening and characterized by intensive care unit (ICU) admission and high mortality. And they are vulnerable to hospital-acquired infection. In such a severe condition, metagenomic next-generation sequencing (mNGS) outperforms for short turnaround time and broad detection spectrum.
Case Presentation:
A 15-year-old male with severe influenza and methicillin-resistant Staphylococcus aureus (MRSA) pneumonia progressed rapidly, initially misdiagnosed as influenza co-infected with Aspergillus for misleading bronchoscopy manifestations. The turnaround time of mNGS is 13 h, which has the potential to expedite the clinical medication process. With the powerful support of mNGS and extracorporeal membrane oxygenation (ECMO), anti-infective therapy was adjusted accordingly, and vital signs gradually stabilized. After tortuous treatment and unremitting efforts, the patient recovered well.
Conclusions:
Rapid mNGS applications, timely medication adjustments, strong ECMO support and active family compliance contribute to this miracle of life. False-negative or false-positive results are alarming, anti-infective medications should be adjusted after a comprehensive review of physical status and other indicators.
Insights
Metagenomic next-generation sequencing (mNGS) rapidly diagnosed severe pneumonia in a teen, enabling timely treatment adjustments. This advanced diagnostic tool, combined with extracorporeal membrane oxygenation (ECMO), proved crucial for patient recovery.
Area of Science:
- Critical care medicine
- Infectious diseases
- Genomics
Background:
- Severe community-acquired pneumonia (sCAP) presents significant mortality risks and necessitates intensive care unit (ICU) admission.
- Patients with sCAP are susceptible to hospital-acquired infections.
- Metagenomic next-generation sequencing (mNGS) offers a broad detection spectrum and rapid turnaround time for diagnosing severe infections.
Approach:
- A 15-year-old male with severe influenza and methicillin-resistant Staphylococcus aureus (MRSA) pneumonia was initially misdiagnosed.
- Bronchoscopy findings were misleading, complicating the initial diagnosis.
- Metagenomic next-generation sequencing (mNGS) provided a rapid diagnosis with a 13-hour turnaround time.
Key Points:
- Metagenomic next-generation sequencing (mNGS) facilitated expedited clinical medication adjustments.
- Extracorporeal membrane oxygenation (ECMO) provided critical cardiorespiratory support.
- The patient's vital signs gradually stabilized following targeted anti-infective therapy.
Conclusions:
- Rapid mNGS application, timely medication adjustments, strong ECMO support, and family compliance were vital for patient recovery.
- Potential for false-negative or false-positive mNGS results necessitates careful interpretation.
- Anti-infective medication adjustments require a comprehensive review of the patient's overall clinical status and other diagnostic indicators.
Related Concept Videos
Pneumonia II: Pathophysiology
Modern Molecular Taxonomy
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....

